EUVIMEDObjevte EUVIMED
Crossref

Plasma Extracellular Vesicles as Biomarkers of Coronary Artery Disease: A Proteomic Analysis Using DIA‐MS‐Based Proteomics

Liliana Moreira-Costa, Elsa D Silva, André Lourenço, Guadalupe Espadas, Eduard Sabidó, António S Barros, Rita Nogueira-Ferreira, Adelino F Leite-Moreira, Rita Ferreira, Diana S Nascimento iD, Fábio Trindade iD, Rui Vitorino iD

PROTEOMICS – Clinical Applications · 2026-11 · 20 (6)

DOI: 10.1002/prca.70064 ↗

At a glance

Journal article in PROTEOMICS – Clinical Applications, published online on 2026-11-17. Written by Liliana Moreira-Costa and 11 co-authors. Institution: RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal. Major MEDLINE topics: Coronary Artery Disease, Extracellular Vesicles, Proteomics, Proteome. 34 references. Funded by: FCT-Portuguese Foundation for Science and Technology, Cardiovascular R&D Center-UnIC, RISE-Health Research Network-From the Lab to the Community.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

Coronary artery disease (CAD) remains one of the leading causes of death worldwide, highlighting the need for improved molecular tools to monitor disease progression and cardiac function. Extracellular vesicles (EVs), released by most cell types into the bloodstream, encapsulate bioactive proteins and can serve as a sensitive matrix for proteomic analysis. The aim of this study was to compare the proteomic profiles of plasma and plasma‐derived EVs using data‐independent acquisition mass spectrometry (DIA‐MS) and to evaluate their associations with clinical indicators of heart failure risk. Experimental design We analyzed plasma and EVs from 28 individuals, including patients undergoing routine clinical follow‐up to assess heart disease risk and patients diagnosed with CAD.

Results

EV‐derived proteome demonstrated stronger and/or more numerous correlations with key clinical parameters of cardiac function and stress, namely Left ventricular ejection fraction (LVEF), B‐type natriuretic peptide (BNP), and Troponin I (TnI), than the neat plasma proteome. These findings underscore the potential of EVs to sensitively reflect dynamic and localized molecular alterations associated with myocardial injury and dysfunction. In contrast, neat plasma proteomes were more closely associated with structural cardiac parameters, such as increased left ventricular mass. Taken together, these results suggest that while both matrices offer complementary insights, EVs may provide a more refined and functionally relevant view of ongoing cardiovascular pathology, particularly in the context of coronary disease‐induced myocardial stress.

Conclusions

Plasma‐derived EVs represent a biologically informative compartment that offers a more sensitive and direct window to the heart status than plasma proteomics. Clinical relevance The stronger association of plasma‐derived EVs with clinically relevant variables supports the value of integrating EV‐based proteomics into cardiovascular research.

Subjects

MeSH terms (MEDLINE)

Coronary Artery DiseaseExtracellular VesiclesProteomicsProteomeHumansBiomarkersFemaleMaleMass SpectrometryMiddle AgedAged

Author keywords

biomarkerscoronary artery disease (CAD)data‐independent acquisition (DIA)extracellular vesicles (EVs)liquid biopsypersonalized medicineplasma‐derived EVsproteomicsrisk stratification

Substances

BiomarkersProteome

Authors and institutions

  • RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Institute for Research and Innovation in Health - i3S, University of Porto, Porto, Portugal.
  • FCUP- Faculdade de Ciências da Universidade do Porto, University of Porto, Portugal, University of Porto, Porto, Portugal.
  • Instituto Nacional de Engenharia Biomédica - INEB, University of Porto, Porto, Portugal.
  • Department of Anaesthesiology, Unidade Local de Saúde São João, Porto, Portugal.
  • Center for Genomics Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

ORCID profiles: Diana S Nascimento, Fábio Trindade, Rui Vitorino

Funding

  • FCT-Portuguese Foundation for Science and Technology
  • Cardiovascular R&D Center-UnIC
  • RISE-Health Research Network-From the Lab to the Community
  • European Proteomics Infrastructure Consortium providing access (EPIC-XS)
  • Horizon 2020 Programme of the European Union (EU)
  • "la Caixa" Banking Foundation and Portuguese Foundation for Science and Technology (FCT)
  • CardioNIR: CARDIOvascular Near-InfraRed spectroscopy probing
  • individual funding through FCT

Cite

APA

Moreira-Costa, L., Silva, E. D., Lourenço, A., Espadas, G., Sabidó, E., Barros, A. S., Nogueira-Ferreira, R., Leite-Moreira, A. F., Ferreira, R., Nascimento, D. S., Trindade, F., & Vitorino, R. (2026). Plasma Extracellular Vesicles as Biomarkers of Coronary Artery Disease: A Proteomic Analysis Using DIA‐MS‐Based Proteomics. PROTEOMICS – Clinical Applications, 20(6). https://doi.org/10.1002/prca.70064

Vancouver

Moreira-Costa L, Silva ED, Lourenço A, Espadas G, Sabidó E, Barros AS, et al. Plasma Extracellular Vesicles as Biomarkers of Coronary Artery Disease: A Proteomic Analysis Using DIA‐MS‐Based Proteomics. PROTEOMICS – Clinical Applications. 2026;20(6). doi:10.1002/prca.70064

BibTeX
@article{MoreiraCosta2026,
  author = {Moreira-Costa, Liliana and Silva, Elsa D and Lourenço, André and Espadas, Guadalupe and Sabidó, Eduard and Barros, António S and Nogueira-Ferreira, Rita and Leite-Moreira, Adelino F and Ferreira, Rita and Nascimento, Diana S and Trindade, Fábio and Vitorino, Rui},
  title = {Plasma Extracellular Vesicles as Biomarkers of Coronary Artery Disease: A Proteomic Analysis Using DIA‐MS‐Based Proteomics},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2026},
  volume = {20},
  number = {6},
  doi = {10.1002/prca.70064}
}
Start for free →